Faricimab, CAS [[1607793-29-2]]

Produktübersicht

• Artikelname: Faricimab, CAS [[1607793-29-2]]
• Artikelnummer: MCE-HY-P99116
• Hersteller Artikelnummer: HY-P99116
• Alternativnummer: MCE-HY-P99116-1MG,MCE-HY-P99116-5MG,MCE-HY-P99116-10MG
• Hersteller: MedchemExpress
• Kategorie: Antikörper
• Alternative Synonym: RG7716, RO-6867461

Produktbeschreibung

Faricimab, an overall good safety and tolerability profile, is a bispecific antibody targeting Angiopoietin-2 (Ang-2) and vascular endothelial growth factor-A (VEGF-A). Faricimab prevents retinal vascular leakage, cell death and inflammation in retinal ischemia/reperfusion (I/R) injury and sCNV mouse models. Faricimab demonstrates statistically superior visual acuity gains versus Ranibizumab (HY-P9951). Faricimab can be used for retinal diseases, such as age-related macular degeneration (w-AMD), diabetic macular edema (DME) and macular edema following retinal vein occlusion (RVO)[1][2][3][4][5].

Produkteigenschaften

• Molekulargewicht: (146.16 kDa)
• Reinheit: 97.97
• CAS Nummer: [1607793-29-2]
• Target-Kategorie: VEGFR

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Inhibitory Antibodies